Welcome to the Neuropsychiatry Section
The Neuropsychiatry program of the University of Pennsylvania's Department of Psychiatry is devoted to the study of brain and behavior in health and disease. By integrating methodologies we aim to advance the understanding and treatment of complex brain disorders such as schizophrenia and related psychotic disorders.
We combine clinical assessment procedures with neurobehavioral measures, neuroimaging, electrophysiology and genomics. Clinical research is linked to basic research by using animal models and biomarkers. The research involves working with individuals and families over time to help understand changes and treatments. We are especially interested in factors that contribute to vulnerability to psychosis as well as those that add to resilience in young people.
News and Events
From Discovery to Recovery: The Role of Genomics
Wednesday, April 25, 2012
3400 Spruce St., Philadelphia PA University of Pennsylvania
Irvine Auditorium
9 AM to 3PM
Many people affected with schizophrenia and their family members have expressed frustration with how confusing and at times ineffective the diagnosis and treatment of brain disorders can be. To many, it often seems that diagnoses and medications change without clear reason or beneficial effect. Research that leads to a more precise understanding of the causes of brain disorders will help to resolve these problems.
The Schizophrenia Research Center and the Conte Center for Neuroscience at the University of Pennsylvania are federally funded research programs. Our research focuses on applying advanced neurobehavioral and neuroimaging methods to study cognition, attention, memory, olfaction, and emotional processing. Our goal is to find the specific causes of schizophrenia in order to advance treatments and better understand how the brain produces behavior.
The goal of this program is to provide participants insight into the link between genomics and psychosis and how this link guides recovery and intervention. Contact: Amy Cassidy
